Partington Syndrome: History
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:

Partington syndrome is a neurological disorder that causes intellectual disability along with a condition called focal dystonia that particularly affects movement of the hands. Partington syndrome usually occurs in males; when it occurs in females, the signs and symptoms are often less severe.

  • genetic conditions

1. Introduction

The intellectual disability associated with Partington syndrome usually ranges from mild to moderate. Some affected individuals have characteristics of autism spectrum disorders that affect communication and social interaction. Recurrent seizures (epilepsy) may also occur in Partington syndrome.

Focal dystonia of the hands is a feature that distinguishes Partington syndrome from other intellectual disability syndromes. Dystonias are a group of movement problems characterized by involuntary, sustained muscle contractions; tremors; and other uncontrolled movements. The term "focal" refers to a type of dystonia that affects a single part of the body, in this case the hands. In Partington syndrome, focal dystonia of the hands, which is called the Partington sign, begins in early childhood and gradually gets worse. This condition typically causes difficulty with grasping movements or using a pen or pencil.

People with Partington syndrome may also have dystonia affecting other parts of the body; dystonia affecting the muscles in the face and those involved in speech may cause impaired speech (dysarthria). People with this disorder may also have an awkward way of walking (gait). Signs and symptoms can vary widely, even within the same family.

2. Frequency

The prevalence of Partington syndrome is unknown. At least 20 cases have been described in the medical literature.

3. Causes

Partington syndrome is caused by mutations in the ARX gene. This gene provides instructions for producing a protein that regulates the activity of other genes. Within the developing brain, the ARX protein is involved with movement (migration) and communication of nerve cells (neurons). In particular, this protein regulates genes that play a role in the migration of specialized neurons (interneurons) to their proper location. Interneurons relay signals between other neurons.

The normal ARX protein contains four regions where a protein building block (amino acid) called alanine is repeated multiple times. These stretches of alanines are known as polyalanine tracts. The most common mutation that causes Partington syndrome, a duplication of genetic material written as c.428_451dup, adds extra alanines to the second polyalanine tract in the ARX protein. This type of mutation is called a polyalanine repeat expansion. The expansion likely impairs ARX protein function and may disrupt normal interneuron migration in the developing brain, leading to the intellectual disability and dystonia characteristic of Partington syndrome.

4. Inheritance

This condition is inherited in an X-linked recessive pattern. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. Females with one altered copy of the gene may have some signs and symptoms related to the condition. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

Rarely, the genetic change that causes Partington syndrome is not inherited but occurs at some point during embryonic development. As cells continue to grow and divide, some of these cells will have the genetic change, and others will not (a situation known as mosaicism). The mosaic nature of these genetic changes lead to relatively mild features of Partington syndrome.

5. Other Names for This Condition

  • MRX36
  • Partington X-linked mental retardation syndrome
  • Partington-Mulley syndrome
  • PRTS
  • X-linked intellectual deficit-dystonia-dysarthria
  • X-linked mental retardation with dystonic movements, ataxia, and seizures

This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/condition/partington-syndrome

References

  1. Cossée M, Faivre L, Philippe C, Hichri H, de Saint-Martin A, Laugel V,Bahi-Buisson N, Lemaitre JF, Leheup B, Delobel B, Demeer B, Poirier K, BiancalanaV, Pinoit JM, Julia S, Chelly J, Devys D, Mandel JL. ARX polyalanine expansionsare highly implicated in familial cases of mental retardation with infantileepilepsy and/or hand dystonia. Am J Med Genet A. 2011 Jan;155A(1):98-105. doi:10.1002/ajmg.a.33785.
  2. Frints SG, Froyen G, Marynen P, Willekens D, Legius E, Fryns JP. Re-evaluationof MRX36 family after discovery of an ARX gene mutation reveals mild neurologicalfeatures of Partington syndrome. Am J Med Genet. 2002 Nov 1;112(4):427-8.
  3. Grønskov K, Diness B, Stahlhut M, Zilmer M, Tümer Z, Bisgaard AM,Brøndum-Nielsen K. Mosaicism for c.431_454dup in ARX causes a mild Partingtonsyndrome phenotype. Eur J Med Genet. 2014 May-Jun;57(6):284-7. doi:10.1016/j.ejmg.2014.03.009.
  4. Partington MW, Turner G, Boyle J, Gécz J. Three new families with X-linkedmental retardation caused by the 428-451dup(24bp) mutation in ARX. Clin Genet.2004 Jul;66(1):39-45.
  5. Poirier K, Lacombe D, Gilbert-Dussardier B, Raynaud M, Desportes V, de BrouwerAP, Moraine C, Fryns JP, Ropers HH, Beldjord C, Chelly J, Bienvenu T. Screeningof ARX in mental retardation families: Consequences for the strategy of moleculardiagnosis. Neurogenetics. 2006 Mar;7(1):39-46.
  6. Sherr EH. The ARX story (epilepsy, mental retardation, autism, and cerebralmalformations): one gene leads to many phenotypes. Curr Opin Pediatr. 2003Dec;15(6):567-71. Review.
  7. Shoubridge C, Fullston T, Gécz J. ARX spectrum disorders: making inroads into the molecular pathology. Hum Mutat. 2010 Aug;31(8):889-900. doi:10.1002/humu.21288. Review.
  8. Suri M. The phenotypic spectrum of ARX mutations. Dev Med Child Neurol. 2005Feb;47(2):133-7. Review.
  9. Turner G, Partington M, Kerr B, Mangelsdorf M, Gecz J. Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two familieswith an identical ARX gene mutation. Am J Med Genet. 2002 Nov 1;112(4):405-11.
More
This entry is offline, you can click here to edit this entry!
ScholarVision Creations